Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...

How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...

The Reverse Stock Split will become effective at 12:01 ... June 05, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein ...

Atara Biotherapeutics (NASDAQ:ATRA) stock plunged 50% in after-hours trading Wednesday after the company said that a Phase 2 study for its drug ATA188 in the treatment of multiple sclerosis failed ...

Atara Biotherapeutics (NASDAQ:ATRA) stock is falling hard on Thursday after the therapeutics company announced results from a Phase 2 clinical trial. The bad news for ATRA stock investors is the ...

Short interest in Atara Biotherapeutics Inc (NASDAQ:ATRA) increased during the last ... betting on the decline of Atara Biotherapeutics's stock. Short interest data is updated every two weeks.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...